Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors

Hydroxamate, as a zinc-binding group (ZBG), prevails in the design of histone deacetylase 6(HDAC6) inhibitors due to its remarkable zinc-chelating capability. However, hydroxamate-associated genotoxicity and mutagenicity have limited the widespread application of corresponding HDAC6 inhibitors in th...

Full description

Bibliographic Details
Main Authors: Yangrong Xu, Hangjun Tang, Yijie Xu, Jialin Guo, Xu Zhao, Qingguo Meng, Junhai Xiao
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/10/3335
_version_ 1797497399716872192
author Yangrong Xu
Hangjun Tang
Yijie Xu
Jialin Guo
Xu Zhao
Qingguo Meng
Junhai Xiao
author_facet Yangrong Xu
Hangjun Tang
Yijie Xu
Jialin Guo
Xu Zhao
Qingguo Meng
Junhai Xiao
author_sort Yangrong Xu
collection DOAJ
description Hydroxamate, as a zinc-binding group (ZBG), prevails in the design of histone deacetylase 6(HDAC6) inhibitors due to its remarkable zinc-chelating capability. However, hydroxamate-associated genotoxicity and mutagenicity have limited the widespread application of corresponding HDAC6 inhibitors in the treatment of human diseases. To avoid such side effects, researchers are searching for novel ZBGs that may be used for the synthesis of HDAC6 inhibitors. In this study, a series of stereoisomeric compounds were designed and synthesized to discover non-hydroxamate HDAC6 inhibitors using α-amino amide as zinc-ion-chelating groups, along with a pair of enantiomeric isomers with inverted L-shaped vertical structure as cap structures. The anti-proliferative activities were determined against HL-60, Hela, and RPMI 8226 cells, and <b>7a</b> and its stereoisomer <b>13a</b> exhibited excellent activities against Hela cells with IC<sub>50</sub> = 0.31 µM and IC<sub>50</sub> = 5.19 µM, respectively. Interestingly, there is a significant difference between the two stereoisomers. Moreover, an evaluation of cytotoxicity toward human normal liver cells HL-7702 indicated its safety for normal cells. X-ray single crystal diffraction was employed to increase insights into molecule structure and activities. It was found that the carbonyl of the amide bond is on the different side from the amino and pyridine nitrogen atoms. To identify possible protein targets to clarify the mechanism of action and biological activity of <b>7a</b>, a small-scale virtual screen using reverse docking for HDAC isoforms (1–10) was performed and the results showed that HDAC6 was the best receptor for <b>7a</b>, suggesting that HDAC6 may be a potential target for <b>7a</b>. The interaction pattern analysis showed that the α-amino amide moiety of <b>7a</b> coordinated with the zinc ion of HDAC6 in a bidentate chelate manner, which is similar to the chelation pattern of hydroxamic acid. Finally, the molecular dynamics simulation approaches were used to assess the docked complex’s conformational stability. In this work, we identified <b>7a</b> as a potential HDAC6 inhibitor and provide some references for the discovery of non-hydroxamic acid HDAC6 inhibitors.
first_indexed 2024-03-10T03:18:44Z
format Article
id doaj.art-f2c2ddc6a4c34e87b1607addebf4260b
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T03:18:44Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-f2c2ddc6a4c34e87b1607addebf4260b2023-11-23T12:24:49ZengMDPI AGMolecules1420-30492022-05-012710333510.3390/molecules27103335Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 InhibitorsYangrong Xu0Hangjun Tang1Yijie Xu2Jialin Guo3Xu Zhao4Qingguo Meng5Junhai Xiao6National Engineering Research Center for the Emergency Drug, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaSchool of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, ChinaNational Engineering Research Center for the Emergency Drug, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaNational Engineering Research Center for the Emergency Drug, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaDepartment of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, ChinaSchool of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, ChinaNational Engineering Research Center for the Emergency Drug, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaHydroxamate, as a zinc-binding group (ZBG), prevails in the design of histone deacetylase 6(HDAC6) inhibitors due to its remarkable zinc-chelating capability. However, hydroxamate-associated genotoxicity and mutagenicity have limited the widespread application of corresponding HDAC6 inhibitors in the treatment of human diseases. To avoid such side effects, researchers are searching for novel ZBGs that may be used for the synthesis of HDAC6 inhibitors. In this study, a series of stereoisomeric compounds were designed and synthesized to discover non-hydroxamate HDAC6 inhibitors using α-amino amide as zinc-ion-chelating groups, along with a pair of enantiomeric isomers with inverted L-shaped vertical structure as cap structures. The anti-proliferative activities were determined against HL-60, Hela, and RPMI 8226 cells, and <b>7a</b> and its stereoisomer <b>13a</b> exhibited excellent activities against Hela cells with IC<sub>50</sub> = 0.31 µM and IC<sub>50</sub> = 5.19 µM, respectively. Interestingly, there is a significant difference between the two stereoisomers. Moreover, an evaluation of cytotoxicity toward human normal liver cells HL-7702 indicated its safety for normal cells. X-ray single crystal diffraction was employed to increase insights into molecule structure and activities. It was found that the carbonyl of the amide bond is on the different side from the amino and pyridine nitrogen atoms. To identify possible protein targets to clarify the mechanism of action and biological activity of <b>7a</b>, a small-scale virtual screen using reverse docking for HDAC isoforms (1–10) was performed and the results showed that HDAC6 was the best receptor for <b>7a</b>, suggesting that HDAC6 may be a potential target for <b>7a</b>. The interaction pattern analysis showed that the α-amino amide moiety of <b>7a</b> coordinated with the zinc ion of HDAC6 in a bidentate chelate manner, which is similar to the chelation pattern of hydroxamic acid. Finally, the molecular dynamics simulation approaches were used to assess the docked complex’s conformational stability. In this work, we identified <b>7a</b> as a potential HDAC6 inhibitor and provide some references for the discovery of non-hydroxamic acid HDAC6 inhibitors.https://www.mdpi.com/1420-3049/27/10/3335HDAC6 inhibitorsnon-hydroxamateα-amino amidesynthesisbioactivity evaluationcrystal structure
spellingShingle Yangrong Xu
Hangjun Tang
Yijie Xu
Jialin Guo
Xu Zhao
Qingguo Meng
Junhai Xiao
Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors
Molecules
HDAC6 inhibitors
non-hydroxamate
α-amino amide
synthesis
bioactivity evaluation
crystal structure
title Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors
title_full Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors
title_fullStr Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors
title_full_unstemmed Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors
title_short Design, Synthesis, Bioactivity Evaluation, Crystal Structures, and In Silico Studies of New α-Amino Amide Derivatives as Potential Histone Deacetylase 6 Inhibitors
title_sort design synthesis bioactivity evaluation crystal structures and in silico studies of new α amino amide derivatives as potential histone deacetylase 6 inhibitors
topic HDAC6 inhibitors
non-hydroxamate
α-amino amide
synthesis
bioactivity evaluation
crystal structure
url https://www.mdpi.com/1420-3049/27/10/3335
work_keys_str_mv AT yangrongxu designsynthesisbioactivityevaluationcrystalstructuresandinsilicostudiesofnewaaminoamidederivativesaspotentialhistonedeacetylase6inhibitors
AT hangjuntang designsynthesisbioactivityevaluationcrystalstructuresandinsilicostudiesofnewaaminoamidederivativesaspotentialhistonedeacetylase6inhibitors
AT yijiexu designsynthesisbioactivityevaluationcrystalstructuresandinsilicostudiesofnewaaminoamidederivativesaspotentialhistonedeacetylase6inhibitors
AT jialinguo designsynthesisbioactivityevaluationcrystalstructuresandinsilicostudiesofnewaaminoamidederivativesaspotentialhistonedeacetylase6inhibitors
AT xuzhao designsynthesisbioactivityevaluationcrystalstructuresandinsilicostudiesofnewaaminoamidederivativesaspotentialhistonedeacetylase6inhibitors
AT qingguomeng designsynthesisbioactivityevaluationcrystalstructuresandinsilicostudiesofnewaaminoamidederivativesaspotentialhistonedeacetylase6inhibitors
AT junhaixiao designsynthesisbioactivityevaluationcrystalstructuresandinsilicostudiesofnewaaminoamidederivativesaspotentialhistonedeacetylase6inhibitors